Get 20% lifetime commission for referring investors to digrin.com
here.
Corbus Pharmaceuticals Holdings, Inc. ( CRBP) - Key Metrics
CRBP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.81 | -$1.53 | -$1.53 |
| 2026Q1 | $0 | -$1.23 | -$1.37 | -$1.37 |
| 2025Q4 | $0 | -$1.54 | -$1.20 | -$1.20 |
| 2025Q3 | $0 | -$1.90 | -$1.26 | -$1.26 |
| 2025Q2 | $0 | -$1.44 | -$1.36 | -$1.36 |
CRBP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.30 |
| 2026Q1 | 0% | -1.91 |
| 2025Q4 | 0% | -1.32 |
| 2025Q3 | 0% | -1.66 |
| 2025Q2 | 0% | -1.20 |
CRBP
Price: $10.26
52 week price:
Earnings Per Share: -6.11 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.8 million
Ebitda: -6.8 millionMarket Capitalization: 195.2 million